CV Sciences Investor Relations Material
Latest events
Q3 2023
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
CV Sciences, Inc. operates as a life science company in North America. The Consumer Products segment engages in manufacturing, marketing, and selling nutraceutical products to wholesale distributors, retailers, and directly to consumers through e-commerce sites. The Specialty Pharmaceutical segment provides commercial and clinical supply of pharmaceutical grade cannabinoids for use in research, therapeutic trials, and for prescription drug formulations.
Latest articles
Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023
Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023
Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023
Ticker symbol
CVSI
Country
🇺🇸 United States